Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 670

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 670
---
 written notice to Kineta or (ii) if the Merger Agreement
is terminated, within ten days following the date of such termination.

Given that the unaudited pro forma condensed combined balance sheet
as of December 31, 2024 assumes that the Mergers occurred on that date, any advances loaned by TuHURA to Kineta under the CTF Agreement would result in a net zero impact to the financial statements of TuHURA. Accordingly, no corresponding pro
forma adjustment was made to the unaudited pro forma condensed combined statement of operations for interest expense as any accrued interest would become intercompany and eliminate in the consolidated financial statements of TuHURA following the
Closing of the Mergers.

447

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

BRepresents the $250,000 of additional financing received on January 5, 2025, as
well as an additional $500,000 of financing which is expected to be received in two separate installments prior to the Closing of the Mergers, that are presented as both cash inflows (for Kineta) and cash outflows (for TuHURA), for an aggregate
amount of $750,000 of subsequent financings that are directly attributable to the Mergers. These payments reflect the working capital loans detailed in the provisions of the Merger Agreement which provides that Kineta may request the extension of
additional working capital loans from TuHURA in increments of $250,000 on dates specified within the Merger Agreement; the last of which is to be advanced by TuHURA to Kineta on or before June 3, 2025, with that amount being contingent upon
TuHURA’s receipt of (A) proceeds from the Concurrent Investment or (B) proceeds from TuHURA’s stockholder warrant exercise payments due on May 30, 2025. As TuHURA’s stockholder warrant exercise payments are expected to
be received in advance of their maturity date (reflected in Adjustment D) in addition to the receipt of the Concurrent Investment by TuHURA in advance of the Closing Date (reflected in Adjustment C), the final $250,000 working capital
loan included in the Merger Agreement is accordingly reflected within this pro forma adjustment.

The unaudited pro forma condensed
combined balance sheet as of December 31, 2024 includes these adjustments to give pro forma effect for both the cash loaned by TuHURA